|
13 Mar 2007 |
Inflazyme Announces Outcome of Review of Phase 2b Asthma Study: Potential Mitigating Factors Identified Which Prevent Clear Interpretation of Results
|
|
10 Mar 2007 |
SCOLR Pharma Announces Research Collaboration with BioCryst Pharmaceuticals
|
|
10 Mar 2007 |
Positive Clinical Data for TASQ - Active Biotech's Novel Treatment of Prostate Cancer
|
|
09 Mar 2007 |
Second lung cancer trial adds to positive data on AS1404
|
|
09 Mar 2007 |
Depomed Completes Patient Enrollment In Phase 3 Clinical Trial Of Gabapentin Gr In Postherpetic Neuralgia
|
|
09 Mar 2007 |
Myriad Genetics Initiates Phase 2 Clinical Trial of Azixa(TM) in Brain Cancer
|
|
08 Mar 2007 |
Lipitor Receives FDA Approval for Five New Indications in Patients With Heart Disease
|
|
08 Mar 2007 |
Stemline Expands its Oncology Pipeline with Acquisition of Clinically Active Compound Directed to "Cancer Stem Cell" Target
|
|
08 Mar 2007 |
NeuroSearch's license partner Abbott initiates clinical Phase II study with ABT-894 in Attention Deficit Hyperactivity Disorder (ADHD)
|
|
08 Mar 2007 |
Liponex Inc. Reports Phase I/II Clinical Trial Data for CRD5
|
|
08 Mar 2007 |
Bentley Announces Approval of Its First Generic Oncology Product in Spain
|
|
07 Mar 2007 |
Tekturna(R) - the first new type of high blood pressure medicine in more than a decade - receives its first approval in the US
|
|
07 Mar 2007 |
Swedish Osteoporosis Drug Begins Trials In Humans
|
|
07 Mar 2007 |
POZEN Announces Positive Outcome for PA 325 Proof of Concept Study
|
|
07 Mar 2007 |
Replidyne Phase II Pediatric Trial Meets Primary Objective
|
|
07 Mar 2007 |
Sunesis Initiates Phase 1 Clinical Trial of SNS-032 in Patients With B-cell Malignancies
|
|
07 Mar 2007 |
Cytochroma Completes Enrollment In Phase II Psoriasis Trial
|
|
07 Mar 2007 |
Wyeth and Progenics to Begin Clinical Testing of a New Formulation of Oral Methylnaltrexone Based on Phase 2 Findings
|
|
07 Mar 2007 |
Savient Announces Completion of Patient Enrollment in Phase 3 Trials of Puricase(R) for Treatment-Failure Gout
|
|
06 Mar 2007 |
Memory Pharmaceuticals Reports Phase 2a Results for MEM 1003 in Bipolar Disorder
|
|
06 Mar 2007 |
Neoprobe Announces Interim Phase 2 Lymphoseek Results
|
|
06 Mar 2007 |
Myriad Presents Additional Flurizan(TM) Phase 2 Study Data Demonstrating Benefit in Alzheimer's Patients
|
|
06 Mar 2007 |
Arena Pharmaceuticals Initiates Phase 2 Clinical Trial of APD125 for the Treatment of Insomnia
|
|
06 Mar 2007 |
LAB International Announces Positive Results From The Open-Label Phase IIB Fentanyl Taifun(R) Trial
|
|
06 Mar 2007 |
AD 923 Commences Phase 1 Clinical Development in the USA
|
